- A policy instituted in 2005 has reduced racial disparities in deceased-donor kidney transplantation among children.
- Since the institution of the policy, called Share 35, fewer children receive kidneys from living donors.
- More than 800 children and adolescents in the U.S. are waiting for a kidney transplant.
Washington, DC (April 26, 2012) -- A policy instituted in 2005 has reduced racial disparities in kidney transplantation among children, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). Children are better off receiving kidneys from live donors, though, and receiving organs from deceased donors can diminish the limited supply of organs available to kidney failure patients on waiting lists.
Everyone with kidney failure deserves a transplanted kidney that works well. But because children with the disease have the greatest long-term potential for a healthy future, in 2005 the United Network for Organ Sharing instituted a policy, Share 35, to preferentially offer kidneys from younger (< 35 years of age) deceased donors, who are more likely to have been healthier at the time of their deaths than older donors, to pediatric patients. (The United Network for Organ Sharing manages the nation's organ transplant system under contract with the federal government.)
What effects have Share 35 had on kidney transplantation? For example, in the past, black and Hispanic children with kidney failure experienced reduced access to transplantation compared with white children. Has Share 35 had an impact on these racial disparities? Also, has Share 35 inadvertently promoted deceased organ donation over living donation for children in need of a kidney transplant?
To answer these and other questions, Sandra Amaral, MD (The Children's Hospital of Philadelphia) and her colleagues analyzed data from the US Renal Data System before and after Share 35. These data applied to 2,299 pediatric kidney failure patients who received a transplant before Share 35 and 2,467 patients who received one after.
Among the major findings:
- On average, patients were 46% more likely to receive a deceased-donor kidney transplant after Share 35 was implemented, with increases of 81% for Hispanics, 45% for blacks, and 37% for whites.
- Patients received a deceased-donor kidney transplant earlier after Share 35: 201 days earlier for Hispanics, 90 days earlier for blacks, and 63 days earlier for whites.
- All races experienced a shift from living- to deceased-donor sources after Share 35, with a 48% reduction in living donors for Hispanics, a 46% reduction for blacks, and a 25% reduction for whites.
These results indicate that Share 35 has attenuated racial disparities in terms of how likely and how soon children will receive a deceased-donor kidney transplant.
"Reduced racial disparities in access to deceased donor kidney transplant for children with end-stage kidney disease is a very positive step toward achieving equity in overall transplant access for all children; however, greater declines in living donors for all pediatric patients, particularly for those of black or Hispanic ethnicity, may be a concern," said Dr. Amaral. "Less access to living donors for children with end-stage kidney disease may mean that these patients have less access to the best quality kidneys and less potential for the best graft survival," she explained. More studies are needed to understand how these changes will impact racial differences in the long-term health of transplanted kidneys.
Study co-authors include Rachel Patzer, PhD, Nancy Kutner, PhD, and William McClellan, MD (Emory University).
Disclosures: The authors reported no financial disclosures.
The article, entitled "Racial Disparities in Access to Pediatric Kidney Transplantation Since Share 35," will appear online at http://jasn.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.